Blood & Cancer

Biosimilars with Dr. Gary Lyman

Advanced bladder cancer: Dr. Arjun Balar talks treatment strategies in a changing field

Gene therapies in hemophilia with Dr. Glenn Pierce

Thrombosis and thrombocytopenia caused by COVID-19 vaccines: How to identify and treat VITT, VIPIT, or TTS

Toward more personalized treatment in prostate cancer: The CCR score predicts metastasis and guides treatment decisions after radiation

Changing perspectives: Dr. Michael Weiner recounts his experiences as an oncologist who became a cancer patient and then a caregiver

Optimizing CAR T-cell therapies in lymphoma: Improving response, fighting cytokine release syndrome, and identifying mechanisms of resistance

Trends in genetic testing for breast and ovarian cancer: Undertesting and racial/ethnic disparities persist

Improving cancer screening in the COVID era: Drive By Flu-FIT allows for socially distanced colorectal cancer screening

Unpacking von Willebrand disease guidelines: Dr. Paula James talks diagnosis and pre-procedure prophylaxis

FDA approvals in hematology and oncology, Part II: New oral formulations, RET and MET inhibitors, and CAR T-cell therapies

How I treat CLL and MCL: From ‘watch and wait’ to BCL2 and BTK inhibitors, CAR T-cell therapy, and transplant

COVID-19 vaccination in cancer patients: Who should be vaccinated and when?

Managing pain in sickle cell crisis with Dr. Ifeyinwa Osunkwo

FDA approvals in hematology and oncology: Novel agents and new tricks for old drugs

NCI-MATCH trial reveals actionable mutations and matches cancer patients to targeted therapies

COVID-19 vaccine 101: Dr. Drew Weissman discusses mechanisms, efficacy, and vaccinating patients with cancer or HIV

Barriers to clinical trial enrollment for patients with gynecologic cancers: Why patients don’t participate and how to improve enrollment

Convalescent plasma for COVID-19, race linked to cancer-associated thrombosis risk, iron deficiency common in pregnancy, and more from ‘Best of ASH’

Thrombosis research from ASH 2020: Khorana score falls short in cancer study, factors predict VTE in cancer patients with COVID-19, and antithrombotics don’t affect severe COVID outcomes

Highlights from SABCS 2020: New data on CDK4/6 inhibitors, omitting chemotherapy and radiotherapy, underreporting toxicity, and predicting outcomes in breast cancer

Best of Blood & Cancer 2020

SABCS 2020: More women may forgo chemo, surgery's role in opioid use, and pregnancy after breast cancer

How does COVID-19 affect patients with hematologic malignancies? The ASH registry provides some answers

News from ASH 2020: 'Practice-changing' results with ruxolitinib in chronic GVHD and no benefit seen with tranexamic acid in patients with blood cancers and severe thrombocytopenia

How I treat GVHD: Dr. James Ferrara explains how biomarkers can predict outcomes and guide the treatment of acute GVHD

Black patients with ES-SCLC get less chemo, CTCs may guide breast cancer treatment, and new FDA approvals for neuroblastoma and prostate cancer

Can aerosolized chemotherapy better treat peritoneal carcinomatosis in patients with gynecologic or gastrointestinal cancers?

News | Checkpoint inhibitors and COVID-19 mortality; HCC rates slow in cities, continue to climb in rural areas

Journal highlights with Dr. David Henry: Managing hematologic conditions in pregnancy, combo for elderly AML, genomics in DLBCL, and COVID-19 updates

Cancer and hepatitis B virus: ASCO's recommendations for HBV screening, monitoring for reactivation, and how to treat patients

How to kill a trial

Post-HSCT care at home: Can maintaining the patient’s microbiome prevent GVHD, improve other outcomes, decrease costs, and reduce the risk of COVID-19?

Real-world checkpoint inhibitor results not as good as trial results

How I treat NSCLC in the era of checkpoint inhibitors and the COVID-19 pandemic

Breast cancer risk with HRT, statins and colorectal cancer, and SBRT for lung metastases

How to use antiemetics: Dr. Paul Hesketh reviews ASCO’s guidelines on antiemetic use in cancer patients receiving checkpoint inhibitors or antineoplastic agents

Patients will gain access to clinical notes, lung cancer screening guidelines fall short, and AML standard remains elusive

Hematology case review: Suspected ITP, presumed heparin-induced thrombocytopenia, and an ‘interesting’ case of anemia

Choosing surgery for older breast cancer patients, delayed screening from COVID-19 could increase deaths, and blood group O linked to decreased SARS-CoV-2 risk

TERAVOLT registry sheds light on characteristics, treatment, and outcomes of patients with thoracic cancers and COVID-19

FDA approves combo immunotherapy for mesothelioma, atezolizumab strikes out in ovarian cancer, and more

The psychiatry of cancer, a crossover from the Psychcast

Global stomach cancer deaths decline but colorectal cancer deaths stagnate; plus, divergent results for paclitaxel/nab-paclitaxel for triple negative breast cancer

ESMO 2020: Late-breaking and practice-changing studies on COVID-19 and breast, lung, gastrointestinal, and other cancers

Hem-Onc News: No benefit from postop radiotherapy in NSCLC, sotorasib is a 'triumph of drug discovery,' and choosing a TKI for ALL

Studying cancer patients with COVID-19: Dr. Brian Rini describes the NCCAPS and CCC19 studies and reviews the latest findings

Waist size and prostate cancer death, AI is on par with radiologists for mammograms, and "How I Treat" MDS from ASH Hematologic Malignancies

Medical school in the COVID era: Two RCSI students explain how the pandemic has affected them

Gene testing for all breast cancer patients with second primary malignancy, atezolizumab for TNBC, pralsetinib for NSCLC, and more